Georgia pharma company recalls thyroid drug for super potency

Alpharetta, Ga.-based Acella Pharmaceuticals recalled 13 lots of NP Thyroid after finding the drug to be super potent.

Advertisement

NP Thyroid tablets, which treat underactive thyroid, consist of levothyroxine and liothyronine. After receiving two reports of adverse events, Acella tested the drug to find that it may have up to 115 percent of its labeled amount of liothyronine, which can cause overactive thyroid.

The negative effects of overactive thyroid include heat intolerance, weight loss, fatigue, muscle weakness, rapid heart rate and hypertension. Pregnant patients who may have consumed prescriptions from a superpotent lot are also at risk of miscarriage and fetal development impairment.

More articles on pharmacy:
WHO suspends hydroxychloroquine trial over safety concerns
Drugmakers worried about Washington’s push to bring drug manufacturing back to US
Anti-anxiety drug prescriptions rise, spur addiction, abuse concerns

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

  • A series of recent FDA safety actions, drug recalls, label updates and court rulings across pharmacy carry operational implications for…

Advertisement

Comments are closed.